← Back to Search

Lab Clasp Device for Sepsis Monitoring

N/A
Waitlist Available
Led By Guruprasad Jambaulikar, MBBS, MPH
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are English speaking
Are 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 150 minutes
Awards & highlights

Study Summary

This trial is designed to compare the accuracy of the Lab Clasp in measuring interstitial fluid lactate to that of venous lactate levels.

Who is the study for?
This trial is for English-speaking adults over 18 in good health, without recent medication changes or unstable medical issues. Participants must not have skin allergies to Lab Clasp materials, a history of serious illness like cancer or heart disease, poor veins for drawing blood, recent hospital stays, substance abuse problems, or be on certain medications like statins.Check my eligibility
What is being tested?
The study tests the Lab Clasp device's ability to monitor sepsis risk by measuring lactate levels in interstitial fluid and comparing these readings with traditional venous blood samples. The goal is to validate this noninvasive method against the current clinical standard.See study design
What are the potential side effects?
Since the Lab Clasp is a noninvasive monitoring device similar to a pulse oximeter used on fingers, side effects are minimal but may include potential skin irritation at the site of application if an allergy exists.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~150 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 150 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparison of average difference lactate readings between Lab Clasp and laboratory reference values.
Secondary outcome measures
Measurement of participant experience

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lab ClaspExperimental Treatment1 Intervention
A finger based device to assay interstitial fluid lactate

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,612 Previous Clinical Trials
11,470,569 Total Patients Enrolled
5 Trials studying Sepsis
26,803 Patients Enrolled for Sepsis
Cambridge Medical Technologies, LLCIndustry Sponsor
2 Previous Clinical Trials
90 Total Patients Enrolled
Guruprasad Jambaulikar, MBBS, MPHPrincipal InvestigatorBrigham and Women's Hospital

Media Library

Lab Clasp Clinical Trial Eligibility Overview. Trial Name: NCT04796285 — N/A
Sepsis Clinical Trial 2023: Lab Clasp Highlights & Side Effects. Trial Name: NCT04796285 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
Guruprasad Jambaulikar, MBBS, MPH 2022. "A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04796285.
All > Sepsis
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top